Symbol: |
CYB5D1
|
Description: |
cytochrome b5 domain containing 1 [Source:HGNC Symbol;Acc:26516]
|
Location: |
Chr17:7761064-7765600[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:159
Gene |
Compound |
Gen_sig |
Exp_pattern |
CYB5D1 |
NSC 105348 |
0.025 |
Up |
CYB5D1 |
NSC 106723 |
0.031 |
Down |
CYB5D1 |
NSC 111135 |
0.036 |
Down |
CYB5D1 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.024 |
Down |
CYB5D1 |
NSC 123978 |
0.025 |
Down |
CYB5D1 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.039 |
Down |
CYB5D1 |
1-Acetylthio-1-phenyl-2-nitroethane |
0.018 |
Down |
CYB5D1 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.046 |
Down |
CYB5D1 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.001 |
Down |
CYB5D1 |
Bromocriptine methanesulfonate |
0.026 |
Down |
CYB5D1 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.04 |
Down |
CYB5D1 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.003 |
Down |
CYB5D1 |
NSC 191393 |
0.011 |
Up |
CYB5D1 |
5-CHLORO-6-[[(3,4-DICHLOROPHENYL)AMINO]METHYL]-2,4-QUINOZOLINEDIAMINE |
0.03 |
Down |
CYB5D1 |
NSC 212446 |
0.004 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:18
Total:2 Current:1
[First] [Prev]  Next Last 
|